Home / Topics / Oral Obesity Medication

Oral Obesity Medication Podcasts

1 episode about Oral Obesity Medication

Novo Nordisk A/S (NVO) Announced Q2 2026 Earnings on August 5, 2026, Reporting "adjusted sales increased by 7% at constant exchange rates, reaching DKK 78.5 billion" for the Quarter artwork

Novo Nordisk A/S (NVO) Announced Q2 2026 Earnings on August 5, 2026, Reporting "adjusted sales increased by 7% at constant exchange rates, reaching DKK 78.5 billion" for the Quarter
Novo Nordisk A/S (NVO)
• 22:17 •Ep 229 •The Earnings Debate